Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the right fund for you.
The SPDR S&P Biotech ETF (XBI) gives investors broad exposure to companies across the biotech industry. Here's how to invest in this ETF.
SPDR S&P BIOTECH ETF (XBI) chart and technical analysis tool allows you to you to add studies and indicators such as SMA,EMA, MACD, On-Balance-Volume etc
作者: 大铲Dachan $美国生科ETF-SPDR(XBI)$顺便给大家推荐由名厨Orbimed(Healthcare Spealist)主理的两个英国上市信托1)World healthcare trust(覆盖不同的医疗子版块)和2)TheBiotechGrowth Trust PLC(主打Biotech)。 这两个信托在3月都办了Investor Update(往上有视频和演示稿),不管是作为菜谱参考还是直接食用...
the fund holds just 30 stocks — a small amount compared to some of its well-known rivals. The median market value of FBT’s holdings is $8.9 billion, but the fund’s components range in weight from just under 2.2% to just under 4.2%, meaning large-caps drive this ETF as much as ...
View HoldingsAs of 03/31/2025 ETF Details CategoryHealth/Biotech Portfolio StyleHealth/Biotech Fund StatusOpen Fund InceptionJanuary 31, 2006 Managers Schneider Donofrio Investment Policy The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segmen...